Individualized therapy based on the combination of mini-PDX and NGS for a patient with metastatic AFP-producing and HER-2 amplified gastric cancer

Mini-patient-derived xenograft (mini-PDX) is a novel, rapid and accurate method used to assess in vivo drug susceptibility. In the present study, a mini-PDX combined with next-generation sequencing (NGS) was used to guide the individualized treatment of a patient with metastatic a-fetoprotein-produc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xiaodan, Xu, Xiaoqing, Zhang, Baonan, Dong, Yun, Gong, Shixia, Gong, Tingjie, Zhang, Feifei, Jin, Chunhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554957/
https://www.ncbi.nlm.nih.gov/pubmed/36245818
http://dx.doi.org/10.3892/ol.2022.13531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554957/
https://www.ncbi.nlm.nih.gov/pubmed/36245818
http://dx.doi.org/10.3892/ol.2022.13531

Ejemplares similares